LCK and cancer: For instance, increased expression of LCK, ITGA5, CGH1 and TNFRSF9 was associated with increased drug sensitivity of cancer cells to ribavirin, nelarabine, zalcitabine, bleomycin, asparaginase, dexrazoxane, palbociclib, etc.